store under nitrogen
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vofopitant dihydrochloride (GR 205171A) is an orally available, selective tachykinin NK1 receptor antagonist that inhibits [3H]SP binding to NK1 with pKi values of 9.5 and 10.6, respectively.Vofopitant dihydrochloride is a potential compound for the treatment of pathological vomiting. Vofopitant dihydrochloride is a potential compound for the treatment of pathological vomiting.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 122.00 | |
5 mg | In stock | $ 297.00 | |
10 mg | In stock | $ 492.00 | |
25 mg | In stock | $ 915.00 | |
50 mg | In stock | $ 1,360.00 | |
100 mg | In stock | $ 1,860.00 |
Description | Vofopitant dihydrochloride (GR 205171A) is an orally available, selective tachykinin NK1 receptor antagonist that inhibits [3H]SP binding to NK1 with pKi values of 9.5 and 10.6, respectively.Vofopitant dihydrochloride is a potential compound for the treatment of pathological vomiting. Vofopitant dihydrochloride is a potential compound for the treatment of pathological vomiting. |
Targets&IC50 | NK1 (human):10.6 (pKi), NK1 (rat):9.5 (pKi) |
Synonyms | GR 205171A, Vofopitant 2HCl |
Molecular Weight | 505.36 |
Formula | C21H25Cl2F3N6O |
CAS No. | 168266-51-1 |
store under nitrogen
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 20 mg/mL (39.58 mM), Sonication is recommended.
DMSO: 20 mg/mL (39.58 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vofopitant dihydrochloride 168266-51-1 GPCR/G Protein Neuroscience Neurokinin receptor GR 205171A Vofopitant 2HCl Vofopitant inhibitor inhibit